ArticleFrontiers in immunology2024

Plasma metabolites as mediators in immune cell-pancreatic cancer risk: insights from Mendelian randomization.

Ke Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.